Ignite Creation Date:
2025-12-24 @ 1:14 PM
Ignite Modification Date:
2026-02-23 @ 6:24 AM
Study NCT ID:
NCT02708095
Status:
COMPLETED
Last Update Posted:
2018-11-21
First Post:
2016-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-03-24
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-10
First Submit QC Date:
None
Study First Post Date:
2016-03-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-28
Results First Submit QC Date:
None
Results First Post Date:
2018-11-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-16
Last Update Post Date:
2018-11-21
Last Update Post Date Type:
ACTUAL